APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Factor VIII

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Factor VIII Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchRecombinant Factor VIII Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Factor VIII Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Recombinant Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Factor VIII Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Factor VIII Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Recombinant Factor VIII market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Factor VIII is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Factor VIII include Takeda, NovoNordisk, Pfizer, Biogen, Bayer, Octapharma and CSL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Factor VIII sales, projected growth trends, production technology, application and end-user industry.

Recombinant Factor VIII Segment by Company

Takeda

NovoNordisk

Pfizer

Biogen

Bayer

Octapharma

CSL

Recombinant Factor VIII Segment by Type

200IU

250IU

Recombinant Factor VIII Segment by Application

Hospital

Pharmacy

Recombinant Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Factor VIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Factor VIII sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Factor VIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200IU Major Manufacturers Table 3. 250IU Major Manufacturers Table 4. Global Recombinant Factor VIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Recombinant Factor VIII Industry Trends Table 8. Recombinant Factor VIII Industry Drivers Table 9. Recombinant Factor VIII Industry Opportunities and Challenges Table 10. Recombinant Factor VIII Industry Restraints Table 11. Global Recombinant Factor VIII Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Recombinant Factor VIII Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Recombinant Factor VIII Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Recombinant Factor VIII Revenue Market Share by Region (2021-2026) Table 15. Global Recombinant Factor VIII Revenue Market Share by Region (2027-2032) Table 16. Global Recombinant Factor VIII Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 17. Global Recombinant Factor VIII Sales by Region (2021-2026) & (units) Table 18. Global Recombinant Factor VIII Sales by Region (2027-2032) & (units) Table 19. Global Recombinant Factor VIII Sales Market Share by Region (2021-2026) Table 20. Global Recombinant Factor VIII Sales Market Share by Region (2027-2032) Table 21. Global Recombinant Factor VIII Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Recombinant Factor VIII Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Recombinant Factor VIII Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Recombinant Factor VIII Sales Market Share by Manufacturers (2021-2026) Table 25. Global Recombinant Factor VIII Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Recombinant Factor VIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Recombinant Factor VIII Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Recombinant Factor VIII Manufacturers, Product Type & Application Table 29. Global Recombinant Factor VIII Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Recombinant Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Recombinant Factor VIII Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Recombinant Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Recombinant Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Recombinant Factor VIII Revenue Market Share by Type (2021-2026) Table 36. Global Recombinant Factor VIII Revenue Market Share by Type (2027-2032) Table 37. Global Recombinant Factor VIII Sales by Type 2021 VS 2025 VS 2032 (units) Table 38. Global Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 39. Global Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 40. Global Recombinant Factor VIII Sales Market Share by Type (2021-2026) Table 41. Global Recombinant Factor VIII Sales Market Share by Type (2027-2032) Table 42. Global Recombinant Factor VIII Price by Type (2021-2026) & (US$/unit) Table 43. Global Recombinant Factor VIII Price by Type (2027-2032) & (US$/unit) Table 44. Global Recombinant Factor VIII Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Recombinant Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Recombinant Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Recombinant Factor VIII Revenue Market Share by Application (2021-2026) Table 48. Global Recombinant Factor VIII Revenue Market Share by Application (2027-2032) Table 49. Global Recombinant Factor VIII Sales by Application 2021 VS 2025 VS 2032 (units) Table 50. Global Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 51. Global Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 52. Global Recombinant Factor VIII Sales Market Share by Application (2021-2026) Table 53. Global Recombinant Factor VIII Sales Market Share by Application (2027-2032) Table 54. Global Recombinant Factor VIII Price by Application (2021-2026) & (US$/unit) Table 55. Global Recombinant Factor VIII Price by Application (2027-2032) & (US$/unit) Table 56. Takeda Company Information Table 57. Takeda Business Overview Table 58. Takeda Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Takeda Recombinant Factor VIII Product Portfolio Table 60. Takeda Recent Development Table 61. NovoNordisk Company Information Table 62. NovoNordisk Business Overview Table 63. NovoNordisk Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. NovoNordisk Recombinant Factor VIII Product Portfolio Table 65. NovoNordisk Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Pfizer Recombinant Factor VIII Product Portfolio Table 70. Pfizer Recent Development Table 71. Biogen Company Information Table 72. Biogen Business Overview Table 73. Biogen Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Biogen Recombinant Factor VIII Product Portfolio Table 75. Biogen Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Bayer Recombinant Factor VIII Product Portfolio Table 80. Bayer Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Octapharma Recombinant Factor VIII Product Portfolio Table 85. Octapharma Recent Development Table 86. CSL Company Information Table 87. CSL Business Overview Table 88. CSL Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. CSL Recombinant Factor VIII Product Portfolio Table 90. CSL Recent Development Table 91. North America Recombinant Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Recombinant Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 94. North America Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 95. North America Recombinant Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 96. North America Recombinant Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 97. North America Recombinant Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Recombinant Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 100. North America Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 101. North America Recombinant Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 102. North America Recombinant Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 103. North America Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Recombinant Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Recombinant Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 107. North America Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 108. North America Recombinant Factor VIII Sales by Country (2027-2032) & (units) Table 109. North America Recombinant Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 110. North America Recombinant Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 111. United States Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 112. Canada Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 113. Mexico Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 114. Europe Recombinant Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Recombinant Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 117. Europe Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 118. Europe Recombinant Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 119. Europe Recombinant Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 120. Europe Recombinant Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Recombinant Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 123. Europe Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 124. Europe Recombinant Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 125. Europe Recombinant Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 126. Europe Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Recombinant Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Recombinant Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 130. Europe Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 131. Europe Recombinant Factor VIII Sales by Country (2027-2032) & (units) Table 132. Europe Recombinant Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 133. Europe Recombinant Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 134. Germany Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 135. France Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 136. U.K. Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 137. Italy Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 138. Russia Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 139. Spain Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 142. Sweden Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 143. Poland Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 144. China Recombinant Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 145. China Recombinant Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 146. China Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 147. China Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 148. China Recombinant Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 149. China Recombinant Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 150. China Recombinant Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 151. China Recombinant Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 152. China Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 153. China Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 154. China Recombinant Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 155. China Recombinant Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 156. Asia Recombinant Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Recombinant Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 159. Asia Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 160. Asia Recombinant Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 161. Asia Recombinant Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 162. Asia Recombinant Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Recombinant Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 165. Asia Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 166. Asia Recombinant Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 167. Asia Recombinant Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 168. Asia Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Recombinant Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Recombinant Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 172. Asia Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 173. Asia Recombinant Factor VIII Sales by Country (2027-2032) & (units) Table 174. Asia Recombinant Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 175. Asia Recombinant Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 176. Japan Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 177. South Korea Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 178. India Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 179. Australia Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Recombinant Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Recombinant Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 185. SAMEA Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 186. SAMEA Recombinant Factor VIII Sales Price by Type (2021-2026) & (US$/unit) Table 187. SAMEA Recombinant Factor VIII Sales Price by Type (2027-2032) & (US$/unit) Table 188. SAMEA Recombinant Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Recombinant Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 191. SAMEA Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 192. SAMEA Recombinant Factor VIII Sales Price by Application (2021-2026) & (US$/unit) Table 193. SAMEA Recombinant Factor VIII Sales Price by Application (2027-2032) & (US$/unit) Table 194. SAMEA Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Recombinant Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Recombinant Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (units) Table 198. SAMEA Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 199. SAMEA Recombinant Factor VIII Sales by Country (2027-2032) & (units) Table 200. SAMEA Recombinant Factor VIII Sales Price by Country (2021-2026) & (US$/unit) Table 201. SAMEA Recombinant Factor VIII Sales Price by Country (2027-2032) & (US$/unit) Table 202. Brazil Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 203. Argentina Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 204. Chile Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 205. Colombia Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 206. Peru Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 208. Israel Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 209. UAE Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 210. Turkey Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 211. Iran Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 212. Egypt Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Recombinant Factor VIII Distributors List Table 216. Recombinant Factor VIII Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Recombinant Factor VIII Image Figure 2. Global Recombinant Factor VIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Factor VIII Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200IU Image Figure 5. 250IU Image Figure 6. Global Recombinant Factor VIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Recombinant Factor VIII Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Recombinant Factor VIII Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Recombinant Factor VIII Revenue (2021-2032) & (US$ Million) Figure 12. Global Recombinant Factor VIII Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Recombinant Factor VIII Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Recombinant Factor VIII Revenue Market Share by Region (2021-2032) Figure 15. Global Recombinant Factor VIII Sales (2021-2032) & (units) Figure 16. Global Recombinant Factor VIII Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 17. Global Recombinant Factor VIII Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Recombinant Factor VIII Sales YoY (2021-2032) & (units) Figure 19. Europe Recombinant Factor VIII Sales YoY (2021-2032) & (units) Figure 20. China Recombinant Factor VIII Sales YoY (2021-2032) & (units) Figure 21. Asia (Excluding China) Recombinant Factor VIII Sales YoY (2021-2032) & (units) Figure 22. South America, Middle East and Africa Recombinant Factor VIII Sales YoY (2021-2032) & (units) Figure 23. Global Recombinant Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Recombinant Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Recombinant Factor VIII Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Recombinant Factor VIII Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Recombinant Factor VIII Revenue Market Share by Type (2021-2032) Figure 29. Global Recombinant Factor VIII Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 30. Global Recombinant Factor VIII Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Recombinant Factor VIII Sales Market Share by Type (2021-2032) Figure 32. Global Recombinant Factor VIII Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Recombinant Factor VIII Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Recombinant Factor VIII Revenue Market Share by Application (2021-2032) Figure 35. Global Recombinant Factor VIII Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 36. Global Recombinant Factor VIII Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Recombinant Factor VIII Sales Market Share by Application (2021-2032) Figure 38. North America Recombinant Factor VIII Revenue Share by Type (2021-2032) Figure 39. North America Recombinant Factor VIII Sales Share by Type (2021-2032) Figure 40. North America Recombinant Factor VIII Revenue Share by Application (2021-2032) Figure 41. North America Recombinant Factor VIII Sales Share by Application (2021-2032) Figure 42. North America Recombinant Factor VIII Revenue Share by Country (2021-2032) Figure 43. North America Recombinant Factor VIII Sales Share by Country (2021-2032) Figure 44. Europe Recombinant Factor VIII Revenue Share by Type (2021-2032) Figure 45. Europe Recombinant Factor VIII Sales Share by Type (2021-2032) Figure 46. Europe Recombinant Factor VIII Revenue Share by Application (2021-2032) Figure 47. Europe Recombinant Factor VIII Sales Share by Application (2021-2032) Figure 48. Europe Recombinant Factor VIII Revenue Share by Country (2021-2032) Figure 49. Europe Recombinant Factor VIII Sales Share by Country (2021-2032) Figure 50. China Recombinant Factor VIII Revenue Share by Type (2021-2032) Figure 51. China Recombinant Factor VIII Sales Share by Type (2021-2032) Figure 52. China Recombinant Factor VIII Revenue Share by Application (2021-2032) Figure 53. China Recombinant Factor VIII Sales Share by Application (2021-2032) Figure 54. Asia Recombinant Factor VIII Revenue Share by Type (2021-2032) Figure 55. Asia Recombinant Factor VIII Sales Share by Type (2021-2032) Figure 56. Asia Recombinant Factor VIII Revenue Share by Application (2021-2032) Figure 57. Asia Recombinant Factor VIII Sales Share by Application (2021-2032) Figure 58. Asia Recombinant Factor VIII Revenue Share by Country (2021-2032) Figure 59. Asia Recombinant Factor VIII Sales Share by Country (2021-2032) Figure 60. SAMEA Recombinant Factor VIII Revenue Share by Type (2021-2032) Figure 61. SAMEA Recombinant Factor VIII Sales Share by Type (2021-2032) Figure 62. SAMEA Recombinant Factor VIII Revenue Share by Application (2021-2032) Figure 63. SAMEA Recombinant Factor VIII Sales Share by Application (2021-2032) Figure 64. SAMEA Recombinant Factor VIII Revenue Share by Country (2021-2032) Figure 65. SAMEA Recombinant Factor VIII Sales Share by Country (2021-2032) Figure 66. Recombinant Factor VIII Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Recombinant Factor VIII Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 200IU
  • 250IU
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Takeda
  • NovoNordisk
  • Pfizer
  • Biogen
  • Bayer
  • Octapharma
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Factor VIII Market by Type
  3. 1.2.1 Global Recombinant Factor VIII Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200IU
  5. 1.2.3 250IU
  6. 1.3 Recombinant Factor VIII Market by Application
  7. 1.3.1 Global Recombinant Factor VIII Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Recombinant Factor VIII Market Dynamics
  1. 2.1 Recombinant Factor VIII Industry Trends
  2. 2.2 Recombinant Factor VIII Industry Drivers
  3. 2.3 Recombinant Factor VIII Industry Opportunities and Challenges
  4. 2.4 Recombinant Factor VIII Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Factor VIII Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Factor VIII Revenue by Region
  3. 3.2.1 Global Recombinant Factor VIII Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Factor VIII Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Factor VIII Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Factor VIII Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Factor VIII Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Factor VIII Sales by Region
  9. 3.4.1 Global Recombinant Factor VIII Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Factor VIII Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Factor VIII Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Factor VIII Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Factor VIII Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Factor VIII Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Factor VIII Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Factor VIII Sales by Manufacturers
  6. 4.2.1 Global Recombinant Factor VIII Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Factor VIII Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Factor VIII Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Factor VIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Factor VIII Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Factor VIII Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Factor VIII Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Factor VIII Tier 1, Tier 2, and Tier 3
5 Recombinant Factor VIII Market by Type
  1. 5.1 Global Recombinant Factor VIII Revenue by Type
  2. 5.1.1 Global Recombinant Factor VIII Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Factor VIII Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Factor VIII Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Factor VIII Sales by Type
  6. 5.2.1 Global Recombinant Factor VIII Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Factor VIII Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Recombinant Factor VIII Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Factor VIII Price by Type
6 Recombinant Factor VIII Market by Application
  1. 6.1 Global Recombinant Factor VIII Revenue by Application
  2. 6.1.1 Global Recombinant Factor VIII Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Factor VIII Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Factor VIII Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Factor VIII Sales by Application
  6. 6.2.1 Global Recombinant Factor VIII Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Factor VIII Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Recombinant Factor VIII Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Factor VIII Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Recombinant Factor VIII Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 NovoNordisk
  8. 7.2.1 NovoNordisk Company Information
  9. 7.2.2 NovoNordisk Business Overview
  10. 7.2.3 NovoNordisk Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 NovoNordisk Recombinant Factor VIII Product Portfolio
  12. 7.2.5 NovoNordisk Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Recombinant Factor VIII Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Biogen
  20. 7.4.1 Biogen Company Information
  21. 7.4.2 Biogen Business Overview
  22. 7.4.3 Biogen Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biogen Recombinant Factor VIII Product Portfolio
  24. 7.4.5 Biogen Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Recombinant Factor VIII Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 Octapharma
  32. 7.6.1 Octapharma Company Information
  33. 7.6.2 Octapharma Business Overview
  34. 7.6.3 Octapharma Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Octapharma Recombinant Factor VIII Product Portfolio
  36. 7.6.5 Octapharma Recent Developments
  37. 7.7 CSL
  38. 7.7.1 CSL Company Information
  39. 7.7.2 CSL Business Overview
  40. 7.7.3 CSL Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CSL Recombinant Factor VIII Product Portfolio
  42. 7.7.5 CSL Recent Developments
8 North America
  1. 8.1 North America Recombinant Factor VIII Market Size by Type
  2. 8.1.1 North America Recombinant Factor VIII Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Factor VIII Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Factor VIII Price by Type (2021-2032)
  5. 8.2 North America Recombinant Factor VIII Market Size by Application
  6. 8.2.1 North America Recombinant Factor VIII Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Factor VIII Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Factor VIII Price by Application (2021-2032)
  9. 8.3 North America Recombinant Factor VIII Market Size by Country
  10. 8.3.1 North America Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Factor VIII Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Factor VIII Market Size by Type
  2. 9.1.1 Europe Recombinant Factor VIII Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Factor VIII Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Factor VIII Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Factor VIII Market Size by Application
  6. 9.2.1 Europe Recombinant Factor VIII Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Factor VIII Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Factor VIII Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Factor VIII Market Size by Country
  10. 9.3.1 Europe Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Factor VIII Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Recombinant Factor VIII Market Size by Type
  2. 10.1.1 China Recombinant Factor VIII Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Factor VIII Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Factor VIII Price by Type (2021-2032)
  5. 10.2 China Recombinant Factor VIII Market Size by Application
  6. 10.2.1 China Recombinant Factor VIII Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Factor VIII Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Factor VIII Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Factor VIII Market Size by Type
  2. 11.1.1 Asia Recombinant Factor VIII Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Factor VIII Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Factor VIII Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Factor VIII Market Size by Application
  6. 11.2.1 Asia Recombinant Factor VIII Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Factor VIII Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Factor VIII Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Factor VIII Market Size by Country
  10. 11.3.1 Asia Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Factor VIII Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Factor VIII Market Size by Type
  2. 12.1.1 SAMEA Recombinant Factor VIII Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Factor VIII Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Factor VIII Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Factor VIII Market Size by Application
  6. 12.2.1 SAMEA Recombinant Factor VIII Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Factor VIII Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Factor VIII Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Factor VIII Market Size by Country
  10. 12.3.1 SAMEA Recombinant Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Factor VIII Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Factor VIII Value Chain Analysis
  2. 13.1.1 Recombinant Factor VIII Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Factor VIII Production Mode & Process
  6. 13.2 Recombinant Factor VIII Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Factor VIII Distributors
  9. 13.2.3 Recombinant Factor VIII Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst